{"transactions":[{"id":754312,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-02T21:16:27.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":46600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following May 29, 2027 subject to the continuous service of the optionee to the Issuer."}],"balance_after":46600,"derivative":{"exercise_price":7.01,"exercise_date":"2027-05-29","expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":46600},"source":{"system":"sec-edgar","filing":"0001191229-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000119122926000002/primarydocument.xml","form_type":"4"}},{"id":754311,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T21:16:27.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":9807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the\nrecipient to the Issuer."}],"balance_after":28861,"source":{"system":"sec-edgar","filing":"0001191229-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000119122926000002/primarydocument.xml","form_type":"4"}},{"id":1124518,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-03T20:31:46.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":39815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer."}],"balance_after":39815,"derivative":{"exercise_price":8.85,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":39815},"source":{"system":"sec-edgar","filing":"0001562180-25-004348","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218025004348/primarydocument.xml","form_type":"4"}},{"id":1124517,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T20:31:46.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":7768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer."}],"balance_after":19054,"source":{"system":"sec-edgar","filing":"0001562180-25-004348","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218025004348/primarydocument.xml","form_type":"4"}},{"id":1393920,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-10-02T20:31:54.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The previously granted option, representing a right to purchase a total of 40,000 shares, became exercisable as follows: 25% of the shares subject to the option vested on May 19, 2015, and the balance vested\nequal installments over the next 24 months."}],"balance_after":0,"derivative":{"exercise_price":3.76,"expiration_date":"2025-05-19","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-24-007144","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218024007144/primarydocument.xml","form_type":"4"}},{"id":1393919,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-02T20:31:54.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":10.1052,"value":101052.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $10.01 to $10.35. The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":11286,"source":{"system":"sec-edgar","filing":"0001562180-24-007144","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218024007144/primarydocument.xml","form_type":"4"}},{"id":1393918,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-02T20:31:54.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":3.76,"value":37600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":21286,"source":{"system":"sec-edgar","filing":"0001562180-24-007144","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218024007144/primarydocument.xml","form_type":"4"}},{"id":1415409,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-09-05T00:20:16.000Z","date":"2024-09-03","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The previously granted option, representing a right to purchase a total of 40,000 shares, became exercisable as follows: 25% of the shares subject to the option vested on May 19, 2015, and the balance vested\nequal installments over the next 24 months."}],"balance_after":10000,"derivative":{"exercise_price":3.76,"expiration_date":"2025-05-19","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-24-006657","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218024006657/primarydocument.xml","form_type":"4"}},{"id":1415408,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T00:20:16.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":700,"price":12.34,"value":8638.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $12.24 to $12.53. The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":11286,"source":{"system":"sec-edgar","filing":"0001562180-24-006657","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218024006657/primarydocument.xml","form_type":"4"}},{"id":1415407,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T00:20:16.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":9300,"price":11.5,"value":106950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $11.24 to $12.20. The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":11986,"source":{"system":"sec-edgar","filing":"0001562180-24-006657","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218024006657/primarydocument.xml","form_type":"4"}},{"id":1415406,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T00:20:16.000Z","date":"2024-09-03","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":3.76,"value":37600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":21286,"source":{"system":"sec-edgar","filing":"0001562180-24-006657","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218024006657/primarydocument.xml","form_type":"4"}},{"id":1440548,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-08-05T22:39:14.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The previously granted option, representing a right to purchase a total of 40,000 shares, became exercisable as follows: 25% of the shares subject to the option vested on May 19, 2015, and the balance vested equal installments over the next 24 months."}],"balance_after":20000,"derivative":{"exercise_price":3.76,"expiration_date":"2025-05-19","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-24-006015","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218024006015/primarydocument.xml","form_type":"4"}},{"id":1440547,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-08-05T22:39:14.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vested in 12 equal monthly installments following June 1, 2016."}],"balance_after":1400,"derivative":{"exercise_price":12.74,"expiration_date":"2026-06-01","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001562180-24-006015","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218024006015/primarydocument.xml","form_type":"4"}},{"id":1440546,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-05T22:39:14.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":100,"price":15,"value":1500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":11286,"source":{"system":"sec-edgar","filing":"0001562180-24-006015","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218024006015/primarydocument.xml","form_type":"4"}},{"id":1440545,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-05T22:39:14.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":400,"price":14.585,"value":5834.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $14.44 to $14.65. The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":11386,"source":{"system":"sec-edgar","filing":"0001562180-24-006015","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218024006015/primarydocument.xml","form_type":"4"}},{"id":1440544,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-05T22:39:14.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":9600,"price":13.45,"value":129120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $13.20 to $14.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":11786,"source":{"system":"sec-edgar","filing":"0001562180-24-006015","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218024006015/primarydocument.xml","form_type":"4"}},{"id":1440543,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-05T22:39:14.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":true,"shares":100,"price":12.74,"value":1274.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":21386,"source":{"system":"sec-edgar","filing":"0001562180-24-006015","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218024006015/primarydocument.xml","form_type":"4"}},{"id":1440542,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-05T22:39:14.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":3.76,"value":37600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":21286,"source":{"system":"sec-edgar","filing":"0001562180-24-006015","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218024006015/primarydocument.xml","form_type":"4"}},{"id":1446152,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-07-30T21:01:47.000Z","date":"2024-07-29","kind":"exercise","planned":true,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vested in 12 equal monthly installments following June 1, 2016."}],"balance_after":1500,"derivative":{"exercise_price":12.74,"expiration_date":"2026-06-01","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001562180-24-005875","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218024005875/primarydocument.xml","form_type":"4"}},{"id":1446151,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-30T21:01:47.000Z","date":"2024-07-29","kind":"sale","planned":true,"acquired":false,"shares":11000,"price":15.045,"value":165495.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $15.00 to $15.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":11286,"source":{"system":"sec-edgar","filing":"0001562180-24-005875","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218024005875/primarydocument.xml","form_type":"4"}},{"id":1446150,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-30T21:01:47.000Z","date":"2024-07-29","kind":"exercise","planned":true,"acquired":true,"shares":11000,"price":12.74,"value":140140.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":22286,"source":{"system":"sec-edgar","filing":"0001562180-24-005875","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218024005875/primarydocument.xml","form_type":"4"}},{"id":1459596,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-07-03T11:55:20.000Z","date":"2024-07-01","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The previously granted option, representing a right to purchase a total of 40,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2015, and the balance vested in equal monthly installments over the 24 months thereafter."}],"balance_after":30000,"derivative":{"exercise_price":3.76,"expiration_date":"2025-05-18","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-24-005566","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218024005566/primarydocument.xml","form_type":"4"}},{"id":1459595,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-03T11:55:20.000Z","date":"2024-07-01","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":11.2691,"value":112691.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $10.98 to $11.76. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide\nupon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":11286,"source":{"system":"sec-edgar","filing":"0001562180-24-005566","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218024005566/primarydocument.xml","form_type":"4"}},{"id":1459594,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-03T11:55:20.000Z","date":"2024-07-01","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":3.76,"value":37600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":21286,"source":{"system":"sec-edgar","filing":"0001562180-24-005566","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218024005566/primarydocument.xml","form_type":"4"}},{"id":1491770,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-06-04T20:42:55.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":24454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer."}],"balance_after":24454,"derivative":{"exercise_price":14.35,"expiration_date":"2034-05-31","underlying":"Common Stock","underlying_shares":24454},"source":{"system":"sec-edgar","filing":"0001562180-24-004654","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218024004654/primarydocument.xml","form_type":"4"}},{"id":1491769,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T20:42:55.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":4790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the recipient to the Issuer."}],"balance_after":11286,"source":{"system":"sec-edgar","filing":"0001562180-24-004654","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218024004654/primarydocument.xml","form_type":"4"}},{"id":1864957,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-06-06T21:12:13.000Z","date":"2023-06-02","kind":"grant","planned":false,"acquired":true,"shares":17892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer."}],"balance_after":17892,"derivative":{"exercise_price":19.72,"expiration_date":"2033-06-02","underlying":"Common Stock","underlying_shares":17892},"source":{"system":"sec-edgar","filing":"0001562180-23-004890","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218023004890/primarydocument.xml","form_type":"4"}},{"id":1864956,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T21:12:13.000Z","date":"2023-06-02","kind":"grant","planned":false,"acquired":true,"shares":3486,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer."}],"balance_after":6496,"source":{"system":"sec-edgar","filing":"0001562180-23-004890","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218023004890/primarydocument.xml","form_type":"4"}},{"id":2220533,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2022-06-28T20:38:34.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":34387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer."}],"balance_after":123715,"source":{"system":"sec-edgar","filing":"0001127602-22-018201","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760222018201/form4.xml","form_type":"4"}},{"id":2240000,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-07T20:20:05.000Z","date":"2022-06-03","kind":"grant","acquired":true,"shares":15324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following June 3, 2022 while the optionee provides continuous service to the Issuer."}],"balance_after":15324,"derivative":{"exercise_price":22.84,"expiration_date":"2032-06-03","underlying":"Common Stock","underlying_shares":15324},"source":{"system":"sec-edgar","filing":"0001562180-22-004878","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218022004878/primarydocument.xml","form_type":"4"}},{"id":2239999,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T20:20:05.000Z","date":"2022-06-03","kind":"grant","acquired":true,"shares":3010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2023 while the recipient provides continuous service to the Issuer."}],"balance_after":3010,"source":{"system":"sec-edgar","filing":"0001562180-22-004878","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218022004878/primarydocument.xml","form_type":"4"}},{"id":2677199,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-08T20:20:06.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following June 4, 2021."}],"balance_after":10000,"derivative":{"exercise_price":35.52,"expiration_date":"2031-06-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-21-004129","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218021004129/primarydocument.xml","form_type":"4"}},{"id":2733559,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2021-05-03T20:07:30.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":7645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer."}],"balance_after":89328,"source":{"system":"sec-edgar","filing":"0001127602-21-014909","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221014909/form4.xml","form_type":"4"}},{"id":3126642,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-02T20:35:17.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following May 29, 2020."}],"balance_after":10000,"derivative":{"exercise_price":37.66,"expiration_date":"2030-05-29","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-20-004069","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218020004069/primarydocument.xml","form_type":"4"}},{"id":3165810,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2020-05-01T20:15:14.000Z","date":"2020-05-01","kind":"grant","acquired":true,"shares":11037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $200,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer."}],"balance_after":81683,"source":{"system":"sec-edgar","filing":"0001127602-20-015029","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220015029/form4.xml","form_type":"4"}},{"id":3501951,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-04T20:22:22.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following May 31, 2019."}],"balance_after":10000,"derivative":{"exercise_price":43.02,"expiration_date":"2029-05-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-19-003295","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218019003295/primarydocument.xml","form_type":"4"}},{"id":3540845,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true}}],"security":"Common Stock, No Par Value","published_at":"2019-05-03T20:14:20.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":10633,"price":23.51,"value":249981.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of Bausch Health Companies Inc. (\"Bausch Health\") on the third business day following their election at the Annual Meeting of Shareholders of Bausch Health (the \"Annual Meeting\").  The RSUs have a grant date value equal to $250,000, vest immediately prior to Bausch Health's next Annual Meeting, and are settled in common shares, no par value, of Bausch Health."}],"balance_after":70646,"source":{"system":"sec-edgar","filing":"0001127602-19-017262","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219017262/form4.xml","form_type":"4"}},{"id":3913900,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-30T20:47:28.000Z","date":"2018-05-25","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following May 25, 2018."}],"balance_after":12500,"derivative":{"exercise_price":49.45,"expiration_date":"2028-05-25","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001562180-18-002721","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000156218018002721/primarydocument.xml","form_type":"4"}},{"id":3943315,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true}}],"security":"Common Stock, No Par Value","published_at":"2018-05-08T20:34:24.000Z","date":"2018-05-03","kind":"grant","acquired":true,"shares":13881,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of Valeant Pharmaceuticals International, Inc. (\"Valeant\") on the third business day following their election at the Annual Meeting of Shareholders of Valeant (the \"Annual Meeting\").  The RSUs have a grant date value equal to $250,000, vest immediately prior to Valeant's next Annual Meeting, and are settled in common shares, no par value, of Valeant."},{"field":"shares","element":"transactionShares","label":"F2","text":"This Amended Form 4 is being filed to correct the number of RSUs acquired on May 3, 2018 as reported on the Form 4 filed on May 4, 2018."}],"balance_after":60013,"source":{"system":"sec-edgar","filing":"0001127602-18-016650","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218016650/form4a.xml","form_type":"4/A","original_submission_date":"2018-05-04"}},{"id":3946114,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true}}],"security":"Common Stock, No Par Value","published_at":"2018-05-04T21:54:29.000Z","date":"2018-05-03","kind":"grant","acquired":true,"shares":14285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of Valeant Pharmaceuticals International, Inc. (\"Valeant\") on the third business day following their election at the Annual Meeting of Shareholders of Valeant (the \"Annual Meeting\").  The RSUs have a grant date value equal to $250,000, vest immediately prior to Valeant's next Annual Meeting, and are settled in common shares, no par value, of Valeant."}],"balance_after":60417,"source":{"system":"sec-edgar","filing":"0001127602-18-016406","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218016406/form4.xml","form_type":"4"}},{"id":4302737,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-26T21:00:18.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following May 24, 2017."}],"balance_after":12500,"derivative":{"exercise_price":18.85,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-17-014566","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191229/000089924317014566/doc4.xml","form_type":"4"}},{"id":4332300,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":42344,"kind":"person","name":"KARABELAS ARGERIS N","position":1,"cik":"0001191229","reported_name":"KARABELAS ARGERIS N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2017-05-05T21:22:35.000Z","date":"2017-05-05","kind":"grant","acquired":true,"shares":25406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Regular annual Restricted Share Units (RSUs) equal to $250,000 granted to non-employee directors in office on the third trading day following the Annual Meeting of Shareholders based on the closing price of registrant common stock on the date prior to the grant.   RSUs represent a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc."}],"balance_after":46132,"source":{"system":"sec-edgar","filing":"0000885590-17-000028","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000088559017000028/primary_doc.xml","form_type":"4"}}]}